1. Home
  2. VKTX vs HAFN Comparison

VKTX vs HAFN Comparison

Compare VKTX & HAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • HAFN
  • Stock Information
  • Founded
  • VKTX 2012
  • HAFN 2012
  • Country
  • VKTX United States
  • HAFN Singapore
  • Employees
  • VKTX N/A
  • HAFN N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • HAFN
  • Sector
  • VKTX Health Care
  • HAFN
  • Exchange
  • VKTX Nasdaq
  • HAFN Nasdaq
  • Market Cap
  • VKTX 2.8B
  • HAFN 2.7B
  • IPO Year
  • VKTX 2015
  • HAFN N/A
  • Fundamental
  • Price
  • VKTX $26.12
  • HAFN $5.13
  • Analyst Decision
  • VKTX Buy
  • HAFN Strong Buy
  • Analyst Count
  • VKTX 12
  • HAFN 1
  • Target Price
  • VKTX $84.00
  • HAFN $6.50
  • AVG Volume (30 Days)
  • VKTX 2.8M
  • HAFN 1.6M
  • Earning Date
  • VKTX 07-23-2025
  • HAFN 05-15-2025
  • Dividend Yield
  • VKTX N/A
  • HAFN 17.81%
  • EPS Growth
  • VKTX N/A
  • HAFN N/A
  • EPS
  • VKTX N/A
  • HAFN 1.20
  • Revenue
  • VKTX N/A
  • HAFN $2,631,664,000.00
  • Revenue This Year
  • VKTX N/A
  • HAFN N/A
  • Revenue Next Year
  • VKTX N/A
  • HAFN $1.88
  • P/E Ratio
  • VKTX N/A
  • HAFN $4.27
  • Revenue Growth
  • VKTX N/A
  • HAFN N/A
  • 52 Week Low
  • VKTX $18.92
  • HAFN $3.61
  • 52 Week High
  • VKTX $81.73
  • HAFN $8.89
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 45.41
  • HAFN N/A
  • Support Level
  • VKTX $26.66
  • HAFN N/A
  • Resistance Level
  • VKTX $28.33
  • HAFN N/A
  • Average True Range (ATR)
  • VKTX 1.37
  • HAFN 0.00
  • MACD
  • VKTX -0.20
  • HAFN 0.00
  • Stochastic Oscillator
  • VKTX 9.58
  • HAFN 0.00

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About HAFN Hafnia Limited Common Shares

Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.

Share on Social Networks: